NCT02377323View on ClinicalTrials.gov

Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif

NACompletedINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

December 31, 2016

Conditions
Multiple Sclerosis
Interventions
OTHER

MACFIMS

Cognitive evaluation of 50 participants

OTHER

MSQoL-54

Quality of life questionnaires

Trial Locations (1)

H2L 4M1

CHUM, Montreal

All Listed Sponsors
collaborator

EMD Serono Canada Inc.

INDUSTRY

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT02377323 - Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif | Biotech Hunter | Biotech Hunter